🇺🇸 Cycloferon in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 11

Most-reported reactions

1. Off Label Use — 2 reports (18.18%)
2. Abdominal Pain — 1 report (9.09%)
3. Asthenia — 1 report (9.09%)
4. Astigmatism — 1 report (9.09%)
5. Blood Pressure Ambulatory Increased — 1 report (9.09%)
6. Chest Discomfort — 1 report (9.09%)
7. Chest Pain — 1 report (9.09%)
8. Circulatory Collapse — 1 report (9.09%)
9. Diarrhoea Haemorrhagic — 1 report (9.09%)
10. Drug Ineffective For Unapproved Indication — 1 report (9.09%)

Source database →

Frequently asked questions

Is Cycloferon approved in United States?

Cycloferon does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Cycloferon in United States?

POLYSAN Scientific & Technological Pharmaceutical Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.